D-0340-2018 Class I Terminated
FDA drug recall D-0340-2018 was initiated by AuroMedics Pharma LLC on Dec 4, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass The recall status is terminated (terminated Mar 17, 2020). Affected quantity: 66,100 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 14, 2018
- Initiation Date
- Dec 4, 2017
- Termination Date
- Mar 17, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 66,100 vials
Product description
Pantoprazole Sodium for Injection, 40 mg per vial, single dose vial, Rx only, Manufactured in India for: AuroMedics Pharma LLC, 6 Wheeling ROad, Dayton, NJ 08810. NDC 55150-202-00
Reason for recall
Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass
Distribution pattern
Product was distributed nationwide in the USA
Code information
Lot # CPO170035
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0340-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026